Lisinopril Impurity 11 | CAS 199002-02-3 - Request Quote
Lisinopril Impurity 11
| SZ CAT No: | SZ-L027034 |
| CAS No | 199002-02-3 |
| Mol.F. | C20H25F3N2O6 |
| Mol.Wt. | 446.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lisinopril Impurity 11 is chemically N2-(1-Ethoxy-1,4-dioxo-4-phenylbutan-2-yl)-N6-(2,2,2-trifluoroacetyl)-L-lysine. Lisinopril Impurity 11 is supplied with detailed characterization data compliant with regulatory guideline. Lisinopril Impurity 11 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lisinopril.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 199002-02-3
Purchase 199002-02-3
Order 199002-02-3
Enquire 199002-02-3
price of 199002-02-3
199002-02-3 Supplier
199002-02-3 Manufacturer
199002-02-3 Exporter
buy high quality Lisinopril Impurity 11
Purchase Lisinopril Impurity 11
Lisinopril Impurity 11 suppliers
Lisinopril Impurity 11 manufacturers
Lisinopril Impurity 11 price
Order Lisinopril Impurity 11
Enquire Lisinopril Impurity 11
Lisinopril Impurity 11 cost
Lisinopril Impurity 11 Supplier
Lisinopril Impurity 11 Distributor
Lisinopril Impurity 11 for Method Validation
Lisinopril Reference Standard
Lisinopril Impurity 11 for ANDA Filing
Lisinopril Impurity 11 for Forced Degradation Studies
Lisinopril Impurity 11 Identification Standards
Lisinopril Impurity 11 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


